Clinical Trial Update: Iperia/Sentus QP Study

View source ↗

Summary

Clinical trial update for the Iperia/Sentus QP study completed by Biotronik, evaluating heart failure and tachyarrhythmia indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Tachyarrhythmia

Drugs mentioned

• Iperia
• Sentus QP

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Heart Failure, Tachyarrhythmia | Status: COMPLETED